After she got a bachelor's degree in medicine in former Sun Yat-sen University of Medical Sciences in 2011, Dr. Peng started to work in the Biotherapy Research Center in Cancer Center. In the same year, she incepted a doctorate in oncology. In 2013, she was promoted to associate chief physican. She mainly focuses on the biotherapy of malignant cander, melanin medical treatment and is familiar with the medical treatment of all sorts of solid tumors.

1. Peng RQ, et al. A pilot study of paclitaxel combined with gemcitabine followed by interleukin-2 and granulocyte macrophage colony-stimulating factor for patients with metastatic melanoma. Cancer Biol Ther. 2012.12.

2. Peng RQ, et al. Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer.BMC Cancer. 2010;10:496. 

3. Peng RQ, et al. Expression of calreticulin is associated with the infiltration of T-cells in stage IIIB colon cancer.World J Gastroenterol.2010；16（19）2428-2434.

4. Gao YF, Peng RQ, et al. The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer. J Transl Med. 2009;7:71